On the other hand, while available evidence seems to suggest that FGF21 patterns may have promising relevance to the assessment of NAFLD status, it alone cannot fully account for differences between no steatosis, simple steatosis, or advanced stages (20, 21, 37, 38). Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.